Literature DB >> 9827285

An outbreak of nontoxigenic Corynebacterium diphtheriae infection: single bacterial clone causing invasive infection among Swiss drug users.

J Gubler1, C Huber-Schneider, E Gruner, M Altwegg.   

Abstract

From 1990 to 1996, a total of 65 patients from whom Corynebacterium diphtheriae had been isolated were reported to the Swiss Federal Office of Public Health. A retrospective review of medical and microbiological records as well as results of ribotyping of available isolates was performed. Twenty-seven patients had acquired their infection without evidence of use of illicit drugs, mostly as a skin infection imported from subtropical areas (20 patients); 38 isolations were associated with intravenous drug use (IVDU) (skin, 15; respiratory tract, 10; blood, 13). Endocarditis was documented in nine patients with bloodstream infection, four of whom died. There were two additional deaths due to overwhelming sepsis. The same ribotype of nontoxigenic C. diphtheriae was found in 31 of the 32 examined isolates associated with IVDU. All non-IVDU isolates had different ribotypes. Among Swiss drug users, a single clone of nontoxigenic C. diphtheriae was found over a period of several years with a high potential to cause severe invasive infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9827285     DOI: 10.1086/514997

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  20 in total

1.  Characterization and comparison of invasive Corynebacterium diphtheriae isolates from France and Poland.

Authors:  E Farfour; E Badell; A Zasada; H Hotzel; H Tomaso; S Guillot; N Guiso
Journal:  J Clin Microbiol       Date:  2011-11-16       Impact factor: 5.948

2.  Emerging and Underrecognized Complications of Illicit Drug Use.

Authors:  Alysse G Wurcel; Elisabeth A Merchant; Roger P Clark; David R Stone
Journal:  Clin Infect Dis       Date:  2015-08-12       Impact factor: 9.079

3.  Cutaneous diphtheria in the urban poor population of Vancouver, British Columbia, Canada: a 10-year review.

Authors:  C F Lowe; K A Bernard; M G Romney
Journal:  J Clin Microbiol       Date:  2011-04-27       Impact factor: 5.948

4.  Human clinical isolates of Corynebacterium diphtheriae and Corynebacterium ulcerans collected in Canada from 1999 to 2003 but not fitting reporting criteria for cases of diphtheria.

Authors:  Leanne M Dewinter; Kathryn A Bernard; Marc G Romney
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

5.  Emergence of an invasive clone of nontoxigenic Corynebacterium diphtheriae in the urban poor population of Vancouver, Canada.

Authors:  M G Romney; D L Roscoe; K Bernard; S Lai; A Efstratiou; A M Clarke
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

6.  Ten Years of Diphtheria Toxin Testing and Toxigenic Cutaneous Diphtheria Investigations in Alberta, Canada: A Highly Vaccinated Population.

Authors:  Natalie C Marshall; Maulik Baxi; Clayton MacDonald; Angela Jacobs; Christopher A Sikora; Gregory J Tyrrell
Journal:  Open Forum Infect Dis       Date:  2021-08-20       Impact factor: 3.835

7.  Emergence of related nontoxigenic Corynebacterium diphtheriae biotype mitis strains in Western Europe.

Authors:  G Funke; M Altwegg; L Frommelt; A von Graevenitz
Journal:  Emerg Infect Dis       Date:  1999 May-Jun       Impact factor: 6.883

8.  Typing of clinical and environmental Aeromonas sp. strains by random amplified polymorphic DNA PCR, repetitive extragenic palindromic PCR, and enterobacterial repetitive intergenic consensus sequence PCR.

Authors:  Ewa Szczuka; Adam Kaznowski
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

9.  Sherlock Holmes and a biological weapon.

Authors:  Setu K Vora
Journal:  J R Soc Med       Date:  2002-02       Impact factor: 18.000

10.  Corynebacterium endocarditis species-specific risk factors and outcomes.

Authors:  Jaime Belmares; Stephanie Detterline; Janet B Pak; Jorge P Parada
Journal:  BMC Infect Dis       Date:  2007-02-06       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.